TY - JOUR AU - Iwata, H; Tamura, K; Doi, T TI - Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: Long-term results of a large phase 1 study with multiple expansion cohorts JO - J Clin Oncol PY - 2018 DO - 10.1200/JCO.2017.77.2285 L3 - PubMed-ID: 29791287 N1 - et al. ER -